Novo Nordisk Shares Are 70% Off Their Peak. Is the Stock Fairly Valued?
Demand for the Danish pharmaceutical giant’s Wegovy pill fell shy of expectations in second quarter results.
Morningstar Europe
Company Earnings
After Earnings, Is Palantir a Buy, a Sell, or Fairly Valued?
After Earnings, Is Amazon Stock a Buy, a Sell, or Fairly Valued?
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
After Earnings, Is Apple Stock a Buy, a Sell, or Fairly Valued?
Novo Nordisk: What We Think of the Stock After Earnings
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
SpaceX: What We Think of the Stock After Earnings
HSBC: What We Think of the Stock After Earnings
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
Palantir: What We Think of the Stock After Earnings
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
Ahead of Earnings, Is Siemens Energy Stock a Buy, a Sell, or Fairly Valued?
Going Into Earnings, Is Siemens Stock a Buy, a Sell, or Fairly Valued?
London Stock Exchange: What We Think of the Stock After Earnings
Apple: What We Think of the Stock After Earnings
Stocks
Funds
Market Insights
Videos
Rolls-Royce Share Price Hits Record High: Is the FTSE 100 Stock Still a Buy?
LVMH, Prada, and Kering: Top Stock Picks in Luxury
Vanguard’s Gemmell: How Bond Investors Can Navigate a Volatile Rate Environment
AI Risks and Resilient Stocks: Morningstar’s EMEA CIO on the Global Market Outlook
LVMH Shares Are Down 50% Off Their Peak. Is a Rebound Coming?
Where the US Stock Market May Be Heading Next and What to Buy Now
Stellantis Share Price Is Down 80%. Can Q2 Earnings Trigger a Recovery?
This AI Stock is Up 75% in 2026. Is the European Chipmaker a Buy Now?
What Investors Should Watch for in the Second Half of 2026
Dividend Investing: How to Find the Right Balance Between Income and Growth
